CompuGroup Medical SE Performance
| CMPUYDelisted Stock | USD 24.80 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0463, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CompuGroup Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding CompuGroup Medical is expected to be smaller as well. CompuGroup Medical right now shows a risk of 0.0%. Please confirm CompuGroup Medical standard deviation and kurtosis , to decide if CompuGroup Medical will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CompuGroup Medical SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, CompuGroup Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 75.9 M | |
| Total Cashflows From Investing Activities | -164 M |
CompuGroup |
CompuGroup Medical Relative Risk vs. Return Landscape
If you would invest 2,480 in CompuGroup Medical SE on November 14, 2025 and sell it today you would earn a total of 0.00 from holding CompuGroup Medical SE or generate 0.0% return on investment over 90 days. CompuGroup Medical SE is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than CompuGroup, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CompuGroup Medical Target Price Odds to finish over Current Price
The tendency of CompuGroup Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 24.80 | 90 days | 24.80 | nearly 4.26 |
Based on a normal probability distribution, the odds of CompuGroup Medical to move above the current price in 90 days from now is nearly 4.26 (This CompuGroup Medical SE probability density function shows the probability of CompuGroup Pink Sheet to fall within a particular range of prices over 90 days) .
CompuGroup Medical Price Density |
| Price |
Predictive Modules for CompuGroup Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CompuGroup Medical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CompuGroup Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CompuGroup Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CompuGroup Medical is not an exception. The market had few large corrections towards the CompuGroup Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CompuGroup Medical SE, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CompuGroup Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.05 | |
β | Beta against Dow Jones | 0.05 | |
σ | Overall volatility | 0.43 | |
Ir | Information ratio | -0.08 |
CompuGroup Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CompuGroup Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CompuGroup Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CompuGroup Medical is not yet fully synchronised with the market data | |
| CompuGroup Medical has a very high chance of going through financial distress in the upcoming years | |
| CompuGroup Medical SE has accumulated 587.08 M in total debt with debt to equity ratio (D/E) of 1.32, which is about average as compared to similar companies. CompuGroup Medical has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CompuGroup Medical until it has trouble settling it off, either with new capital or with free cash flow. So, CompuGroup Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CompuGroup Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CompuGroup to invest in growth at high rates of return. When we think about CompuGroup Medical's use of debt, we should always consider it together with cash and equity. |
CompuGroup Medical Fundamentals Growth
CompuGroup Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CompuGroup Medical, and CompuGroup Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CompuGroup Pink Sheet performance.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.89 B | |||
| Shares Outstanding | 52.23 M | |||
| Price To Earning | 25.48 X | |||
| Price To Book | 2.94 X | |||
| Price To Sales | 1.97 X | |||
| Revenue | 1.03 B | |||
| EBITDA | 213.99 M | |||
| Cash And Equivalents | 120.07 M | |||
| Cash Per Share | 2.30 X | |||
| Total Debt | 587.08 M | |||
| Debt To Equity | 1.32 % | |||
| Book Value Per Share | 12.87 X | |||
| Cash Flow From Operations | 165.27 M | |||
| Earnings Per Share | 1.47 X | |||
| Total Asset | 1.79 B | |||
About CompuGroup Medical Performance
Evaluating CompuGroup Medical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if CompuGroup Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CompuGroup Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. Compugroup Medical is traded on OTC Exchange in the United States.Things to note about CompuGroup Medical performance evaluation
Checking the ongoing alerts about CompuGroup Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CompuGroup Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CompuGroup Medical is not yet fully synchronised with the market data | |
| CompuGroup Medical has a very high chance of going through financial distress in the upcoming years | |
| CompuGroup Medical SE has accumulated 587.08 M in total debt with debt to equity ratio (D/E) of 1.32, which is about average as compared to similar companies. CompuGroup Medical has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CompuGroup Medical until it has trouble settling it off, either with new capital or with free cash flow. So, CompuGroup Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CompuGroup Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CompuGroup to invest in growth at high rates of return. When we think about CompuGroup Medical's use of debt, we should always consider it together with cash and equity. |
- Analyzing CompuGroup Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CompuGroup Medical's stock is overvalued or undervalued compared to its peers.
- Examining CompuGroup Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CompuGroup Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CompuGroup Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CompuGroup Medical's pink sheet. These opinions can provide insight into CompuGroup Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in CompuGroup Pink Sheet
If you are still planning to invest in CompuGroup Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CompuGroup Medical's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |